These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10897012

  • 1. Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction.
    Vilà MR, Nicolás A, Morote J, de I, Meseguer A.
    Cancer; 2000 Jul 01; 89(1):152-64. PubMed ID: 10897012
    [Abstract] [Full Text] [Related]

  • 2. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M, Hirooka Y, Kaibara N.
    Cancer; 2002 Nov 01; 95(9):1938-45. PubMed ID: 12404288
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B, Miki T.
    J Clin Oncol; 2005 Jan 20; 23(3):448-54. PubMed ID: 15572731
    [Abstract] [Full Text] [Related]

  • 4. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Dec 01; 12(23):6989-97. PubMed ID: 17145819
    [Abstract] [Full Text] [Related]

  • 5. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T, Miyagawa I.
    Int J Urol; 2006 Mar 01; 13(3):257-64. PubMed ID: 16643620
    [Abstract] [Full Text] [Related]

  • 6. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
    Teratani T, Domoto T, Kuriki K, Kageyama T, Takayama T, Ishikawa A, Ozono S, Nozawa R.
    Urology; 2007 Feb 01; 69(2):236-40. PubMed ID: 17320655
    [Abstract] [Full Text] [Related]

  • 7. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K, Cheale M, Coleman N, Fox SB.
    Clin Cancer Res; 2002 Apr 01; 8(4):1075-81. PubMed ID: 11948116
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T, Furuya M, Nishiyama M, Kasuya Y, Kimura S, Ichikawa T, Ueda T, Nikaido T, Ito H, Ishikura H.
    Cancer; 2005 Jan 15; 103(2):258-67. PubMed ID: 15578685
    [Abstract] [Full Text] [Related]

  • 9. [Screening of novel genes differentially expressed in human renal cell carcinoma by suppression subtractive hybridization].
    Ai JK, Huang X, Wang YJ, Bai Y, Lu YQ, Ye XJ, Xin DQ, Na YQ, Zhang ZW, Guo YL.
    Ai Zheng; 2002 Oct 15; 21(10):1065-9. PubMed ID: 12508644
    [Abstract] [Full Text] [Related]

  • 10. Differential gene expression identifies subgroups of renal cell carcinoma.
    Skubitz KM, Zimmermann W, Kammerer R, Pambuccian S, Skubitz AP.
    J Lab Clin Med; 2006 May 15; 147(5):250-67. PubMed ID: 16697773
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
    Romero JM, Aptsiauri N, Vazquez F, Cozar JM, Canton J, Cabrera T, Tallada M, Garrido F, Ruiz-Cabello F.
    Tissue Antigens; 2006 Oct 15; 68(4):303-10. PubMed ID: 17026465
    [Abstract] [Full Text] [Related]

  • 12. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips].
    Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G.
    Verh Dtsch Ges Pathol; 1999 Oct 15; 83():225-32. PubMed ID: 10714215
    [Abstract] [Full Text] [Related]

  • 13. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M, Yang XJ, Sugimura J, Backdahl J, Tretiakova M, Qian CN, Gray SG, Knapp R, Anema J, Kahnoski R, Nicol D, Vogelzang NJ, Furge KA, Kanayama H, Kagawa S, Teh BT.
    Oncogene; 2003 Oct 02; 22(43):6810-8. PubMed ID: 14555994
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC, Barocas DA, Chen YT, Yang XJ, Scherr DS, Tu JJ.
    J Urol; 2009 May 02; 181(5):2305-11. PubMed ID: 19303095
    [Abstract] [Full Text] [Related]

  • 15. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J, Rebmann V, Grosse-Wilde H, Luboldt H, Ruebben H, Drexler I, Sutter G, Huber C, Seliger B.
    Cancer Res; 2003 Jul 15; 63(14):4107-11. PubMed ID: 12874014
    [Abstract] [Full Text] [Related]

  • 16. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, Jonas D, Libermann TA.
    Clin Cancer Res; 2005 Aug 15; 11(16):5730-9. PubMed ID: 16115910
    [Abstract] [Full Text] [Related]

  • 17. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R, Ratschek M, Rehak P, Schips L, Langner C.
    Urology; 2004 Apr 15; 63(4):651-5. PubMed ID: 15072872
    [Abstract] [Full Text] [Related]

  • 18. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA, Tölle A, Jung M, Fritzsche FR, Haendler B, Kristiansen I, Gaspert A, Johannsen M, Jung K, Kristiansen G.
    Eur Urol; 2009 Mar 15; 55(3):669-78. PubMed ID: 18450365
    [Abstract] [Full Text] [Related]

  • 19. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y, Katagiri T.
    Int J Oncol; 2006 Oct 15; 29(4):799-827. PubMed ID: 16964377
    [Abstract] [Full Text] [Related]

  • 20. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
    Patel SK, Ma N, Monks TJ, Lau SS.
    Mol Carcinog; 2003 Nov 15; 38(3):141-54. PubMed ID: 14587099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.